Holen Sie sich die Stockscreener-App
4.065
2.63%
-0.115
Briacell Therapeutics Corp Aktie (BCTX) Neueste Nachrichten
(BCT) Long Term Investment Analysis (BCT:CA) - Stock Traders Daily
Published on: 2026-02-07 21:02:33 - baoquankhu1.vn
Published on: 2026-02-07 19:20:19 - baoquankhu1.vn
Market Recap: Does BriaCell Therapeutics Corp align with a passive investing strategyWeekly Stock Recap & Safe Entry Zone Identification - baoquankhu1.vn
Published on: 2026-02-06 19:26:35 - baoquankhu1.vn
Published on: 2026-02-04 18:01:12 - baoquankhu1.vn
Stocks in play: BriaCell Therapeutics Corp. - Barchart.com
Big Picture: Should I buy BriaCell Therapeutics Corp Equity Warrant stock nowEarnings Recap Report & AI Enhanced Market Trend Forecasts - baoquankhu1.vn
How does BriaCell Therapeutics Corp. Equity Warrant compare to its peersJuly 2025 Momentum & Weekly Watchlist for Consistent Profits - mfd.ru
Will BriaCell Therapeutics Corp. stock hit new highs in YEAR2025 Risk Factors & AI Powered Trade Plan Recommendations - mfd.ru
What’s the profit margin of BriaCell Therapeutics Corp. Equity WarrantPortfolio Gains Summary & Weekly Top Stock Performers List - mfd.ru
BriaCell Brief: Says Patients' Images Show Regression And Resolution Of Metastasized Tumors And Immune Activation - marketscreener.com
(BCT) Equity Market Report (BCT:CA) - Stock Traders Daily
BriaCell Therapeutics (BCTX) Shows Promising Results in Metastatic Breast Cancer Treatment - GuruFocus
BriaCell Treatment Shows Significant Efficacy in Cancer Patients - Intellectia AI
BriaCell Patients’ Images Show Regression and Resolution of Metastasized Tumors and Immune Activation - Sahm
Can BriaCell Therapeutics Corp. ride the EV waveJuly 2025 Pullbacks & Accurate Buy Signal Alerts - mfd.ru
BriaCell reports long-term survival data in metastatic breast cancer By Investing.com - Investing.com India
BriaCell Therapeutics Corp. - Baystreet.ca
BriaCell (BCTX) Reports Promising Phase 2 Survival Data - GuruFocus
BriaCell Therapeutics Says Phase 2 Metastatic Breast Cancer Patients Survival Data Exceed Benchmarks - marketscreener.com
BriaCell's New Therapy Significantly Extends Survival in Breast Cancer Patients - Intellectia AI
BriaCell reports long-term survival data in metastatic breast cancer - Investing.com
BriaCell Highlights Extended >18-47 Months Survival in Phase 2 Metastatic Breast Cancer Patients - The Manila Times
Growth Value: Is BriaCell Therapeutics Corp a defensive stockJuly 2025 Rallies & Step-by-Step Trade Execution Guides - baoquankhu1.vn
(BCT) Strategic Investment Report (BCT:CA) - Stock Traders Daily
Smart Money: Is BriaCell Therapeutics Corp Equity Warrant benefiting from innovation trendsLayoff News & Weekly Stock Breakout Alerts - baoquankhu1.vn
(BCT) Strategic Equity Report (BCT:CA) - Stock Traders Daily
(BCT) Stock Trading Blueprint (BCT:CA) - Stock Traders Daily
Is the Market Bullish or Bearish on BriaCell Therapeutics Corp? - Benzinga
Market Moves: Can BriaCell Therapeutics Corp Equity Warrant continue delivering strong returnsWeekly Trade Summary & Accurate Buy Signal Alerts - baoquankhu1.vn
Surprises Report: Is Simpple Ltd stock a value trapJuly 2025 PostEarnings & Free Community Supported Trade Ideas - baoquankhu1.vn
ETF Watch: Does BriaCell Therapeutics Corp have a sustainable dividendMarket Risk Analysis & Verified Stock Trade Ideas - baoquankhu1.vn
The Globe’s stars and dogs for the week - The Globe and Mail
Philadelphia cancer therapy developer raises $30M amid signs of thaw in biotech funding - The Business Journals
Weekly Buzz: LYRA Slashes Jobs; FDA Okays FBIO's ZYCUBO; BSX To Acquire PEN; BCTX On Watch - RTTNews
BriaCell Therapeutics Announces Closing of US$30 million Public Offering - The Manila Times
BriaCell closes $30 million public offering to fund cancer immunotherapy By Investing.com - Investing.com Nigeria
BrianCell Therapeutics drops 10%, prices $30M offering at $5.59 per unit - MSN
BriaCell Therapeutics Completes $30 Million Public Offering - TipRanks
BriaCell closes $30 million public offering to fund cancer immunotherapy - Investing.com India
BriaCell Therapeutics Signs Multiple Material Agreements - TradingView
Why did BCTX stock surge 50% today? - MSN
BriaCell Therapeutics shares sink after $30 million capital raise - MSN
Market Review: Whats the profit margin of BriaCell Therapeutics Corp Equity Warrant2025 Pullback Review & Long-Term Growth Stock Strategies - baoquankhu1.vn
Quarterly Risk: What is the next catalyst for BriaCell Therapeutics CorpJuly 2025 Weekly Recap & Weekly Watchlist for Hot Stocks - baoquankhu1.vn
BriaCell Raises $30 Million Through Public Offering of Units and Listed Warrants - The Globe and Mail
Market Trends: Does BriaCell Therapeutics Corp Equity Warrant stock have upside surprise potentialGDP Growth & Stock Market Timing Techniques - baoquankhu1.vn
Aug Catalysts: What is BriaCell Therapeutics Corp Equity Warrants valuation compared to sectorWeekly Profit Analysis & Free Fast Gain Swing Trade Alerts - baoquankhu1.vn
U.S. Retail Sales Rise 0.6% MoM, Tech Stocks Decline - Intellectia AI
Crude Oil Gains Over 1%; US Retail Sales Rise 0.6% In November - Benzinga
Glaukos Corp (GKOS) Projects FY25 Sales of $507 Million, Shares Drop 12.1% - Intellectia AI
The $69B Precision Pivot: Why Biomarker Platforms are Igniting a New Oncology Gold Rush - The Globe and Mail
0.30%
0.42%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):